Home

HTA Programme

Selecting Criteria

Strategic mission

  • Build trust between stakeholders as the key to facilitating best practices. The recognition of CIRS as an independent, science-driven neutral platform enables us to work closely with regulatory, HTA and Payer agencies and to serve as a conduit for discussions to develop regional and global best practices
  • Develop consensus among stakeholders through science-based insight. CIRS research experience and methodologies developed and validated in the regulatory arena are applied to the HTA environment to improve transparency, predictability and efficiency
  • Facilitate access of new innovative medicines to patients. Through the combination of Workshops, research, targeted presentations and publications and regular interaction with agencies, CIRS is able to identify, refine and encourage best practice

 Activities

  • Workshops: focus on issues related to improving predictability, transparency and decision making
  • Systematic Process Maps across countries have been developed to enable the comparison and understanding of how evidence moves from registration to reimbursement
  • Benchmarking: benchmarking of time and process to enable comparison between systems and to identify trends
  • Industry and Agency meetings